Food allergy frequently precedes or coexists with respiratory allergy, and although restriction of contacts with the allergen is the elected clinical procedure, oral immunotherapy (OIT) has proven to be surprisingly efficient in clinical trials. We investigated whether prolonged restriction and voluntary exposure of previously sensitized (immunized) mice to ovalbumin (OVA) in the drinking water would alter subsequent responses to bronchial (aerosol) challenge with OVA. We found a significant suppression of bronchial inflammation, with marked reduction of eosinophils. IL-4, CCL-2, and CCL-11 are not associated with elevation in IL-10 production or Foxp3 expression, with only minor digestive symptoms.
Keyphrases
- drinking water
- clinical trial
- high fat diet induced
- liver fibrosis
- liver injury
- oxidative stress
- poor prognosis
- health risk
- health risk assessment
- regulatory t cells
- drug induced
- mouse model
- randomized controlled trial
- wild type
- depressive symptoms
- atomic force microscopy
- allergic rhinitis
- risk assessment
- phase ii
- open label
- atopic dermatitis
- heavy metals
- respiratory tract
- mass spectrometry
- water soluble
- single molecule